Skip to main content
Download PDF
Download ePub

Retraction Note: SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88

Journal of Experimental & Clinical Cancer Research volume 42, Article number: 16 (2023) Cite this article

The Original Article was published on 29 August 2018

Retraction Note: J Exp Clin Cancer Res 37, 202 (2018)

https://doi.org/10.1186/s13046-018-0875-3

The Editor-in-Chief has retracted this article because data presented in Figs. 2, 3 and 4 were duplicated from previously published articles. Specifically, a set of staining images in Fig. 2I had previously been published as Fig. 3E in [1]. The actin blot in Fig. 3D had been published as part of Fig. 4B in [2], and as part of 7H in [3]. The BT474 blot in Fig. 4C was previously published as P2 in Fig. 2F of [4]. The SKBR-3 MyD88 blot in Fig. 4D originally appeared as snail in Fig. 5D in [5]. The Editor-in-Chief no longer has confidence in the results and conclusions of this article. Huaying Dong states that all authors agree to this retraction.

References

  1. Liu H, et al. Long noncoding RNA TUG1 is a diagnostic factor in lung adenocarcinoma and suppresses apoptosis via epigenetic silencing of BAX. Oncotarget. 2017;8(60):101899–910. Web. 28 Nov. 2022. https://doi.org/10.18632/oncotarget.22058.

    Article  Google Scholar 

  2. Dong H, Wang W, Mo S, et al. Long non-coding RNA SNHG14 induces trastuzumab resistance of breast cancer via regulating PABPC1 expression through H3K27 acetylation. J Cell Mol Med. 2018;22:4935–47. https://doi.org/10.1111/jcmm.13758.

    Article  CAS  Google Scholar 

  3. Kang M, Ren M, Li Y, et al. Exosome-mediated transfer of lncRNA PART1 induces gefitinib resistance in esophageal squamous cell carcinoma via functioning as a competing endogenous RNA. J Exp Clin Cancer Res. 2018;37:171. https://doi.org/10.1186/s13046-018-0845-9.

    Article  CAS  Google Scholar 

  4. Zhang W, Cai X, Yu J, Lu X, Qian Q, Qian W. Exosome-mediated transfer of lncRNA RP11-838N2.4 promotes erlotinib resistance in non-small cell lung cancer Retraction in /10.3892/ijo.2022.5458. Int J Oncol. 2018;53(2):527–38.

    CAS  Google Scholar 

  5. Ji Q, Liu X, Han Z, et al. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression. BMC Cancer. 2015;15:97. https://doi.org/10.1186/s12885-015-1119-y.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General Surgery, Hainan General Hospital, Jinan University, No.19 Xiu Hua Road, Xiuying District, Haikou city, 570311, Hainan Province, China

    Huaying Dong, Wei Wang, Ru Chen, Kejian Zou, Jing Han & Fan Zhang

  2. Department of Science and Education, Hainan Maternal and Child health hospital, Haikou, 570206, Hainan, China

    Shaowei Mo

  3. Department of Obstetrics and Gynecology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, 400010, China

    Jianguo Hu

Authors
  1. Huaying Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wei Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shaowei Mo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ru Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kejian Zou
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jing Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Fan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jianguo Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Huaying Dong.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

About this article

Verify currency and authenticity via CrossMark

Cite this article

Dong, H., Wang, W., Mo, S. et al. Retraction Note: SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88. J Exp Clin Cancer Res 42, 16 (2023). https://doi.org/10.1186/s13046-023-02596-2

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13046-023-02596-2

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us